专家论坛

超声造影及超声弹性成像在良恶性甲状腺结节鉴别诊断中的应用进展

展开
  • 上海交通大学医学院附属瑞金医院超声科,上海 200025

收稿日期: 2020-08-01

  网络出版日期: 2022-07-15

本文引用格式

周伟, 侯怡卿, 詹维伟 . 超声造影及超声弹性成像在良恶性甲状腺结节鉴别诊断中的应用进展[J]. 诊断学理论与实践, 2020 , 19(04) : 344 -349 . DOI: 10.16150/j.1671-2870.2020.04.004

参考文献

[1] Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6):394-424.
[2] Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66(2):115-132.
[3] Xu SY, Zhan WW, Wang WH. Evaluation of thyroid nodules by a scoring and categorizing method based on sonographic features[J]. J Ultrasound Med, 2015, 34(12):2179-2185.
[4] Zhan J, Ding H. Application of contrast-enhanced ultrasound for evaluation of thyroid nodules[J]. Ultrasonography, 2018, 37(4):288-297.
[5] Zhang J, Zhang X, Meng Y, et al. Contrast-enhanced ultrasound for the differential diagnosis of thyroid nodules: An updated meta-analysis with comprehensive heterogeneity analysis[J]. PLoS One, 2020, 15(4):e0231775.
[6] Yuan Z, Quan J, Yunxiao Z, et al. Association between real-time contrast-enhanced ultrasound characteristics and thyroid carcinoma size[J]. Mol Clin Oncol, 2015, 3(4):743-746.
[7] 陶菁, 彭清海. 超声造影技术在甲状腺良恶性结节鉴别中的应用[J]. 医学综述, 2018, 24(1):170-174.
[8] Zhou X, Zhou P, Hu Z, et al. Diagnostic efficiency of quantitative contrast-enhanced ultrasound indicators for discriminating benign from malignant solid thyroid nodules[J]. J Ultrasound Med, 2018, 37(2):425-437.
[9] Gao Z, Lu Q, Yan J. Value of differential diagnosis of contrast-enhanced ultrasound in benign and malignant thyroid nodules with microcalcification[J]. Oncol Lett, 2019, 17(5):4545-4549.
[10] Peng Q, Niu C, Zhang Q, et al. Mummified thyroid nodu-les: Conventional and contrast-enhanced ultrasound features[J]. J Ultrasound Med, 2019, 38(2):441-452.
[11] Asteria C, Giovanardi A, Pizzocaro A, et al. US-elastography in the differential diagnosis of benign and malignant thyroid nodules[J]. Thyroid, 2008, 18(5):523-531.
[12] Asteria C, Giovanardi A, Pizzocaro A, et al. Elastography: new developments in ultrasound for predicting malignancy in thyroid nodules[J]. Thyroid, 2008, 18(5):523-531.
[13] Görgülü FF. Which is the best reference tissue for strain elastography in predicting malignancy in thyroid nodules, the sternocleidomastoid muscle or the thyroid parenchyma?[J]. J Ultrasound Med, 2019, 38(11):3053-3064.
[14] 施燕芸, 戚庭月. 超声弹性成像在甲状腺结节中的应用进展[J]. 医学综述, 2017, 23(10):2035-2040.
[15] Zhao CK, Xu HX. Ultrasound elastography of the thyroid: principles and current status[J]. Ultrasonography, 2019, 38(2):106-124.
[16] Sun J, Cai J, Wang X. Real-time ultrasound elastography for differentiation of benign and malignant thyroid no-dules: a meta-analysis[J]. J Ultrasound Med, 2014, 33(3):495-502.
[17] Trimboli P, Guglielmi R, Monti S, et al. Ultrasound sensitivity for thyroid malignancy is increased by real-time elastography: a prospective multicenter study[J]. J Clin Endocrinol Metab, 2012, 97(12):4524-4530.
[18] Zhang Y, Zhou P, Tian SM, et al. Usefulness of combined use of contrast-enhanced ultrasound and TI-RADS classification for the differentiation of benign from malignant lesions of thyroid nodules[J]. Eur Radiol, 2017, 27(4):1527-1536.
[19] Wang Y, Nie F, Liu T, et al. Revised value of contrast-enhanced ultrasound for solid hypo-echoic thyroid no-dules graded with the thyroid imaging reporting and data system[J]. Ultrasound Med Biol, 2018, 44(5):930-940.
[20] 季沁, 周一帆, 陈茉, 等. 弹性成像联合ACR-TIRADS诊断甲状腺结节良恶性的临床价值研究[J]. 诊断学理论与实践, 2019, 18(3):307-312.
[21] Li X, Hou XJ, Du LY, et al. Virtual Touch Tissue Ima-ging and Quantification(VTIQ) combined with the American College of Radiology Thyroid Imaging Reporting and Data System (ACR TI-RADS) for malignancy risk stratification of thyroid nodules[J]. Clin Hemorheol Microcirc, 2019, 72(3):279-291.
[22] Jin ZQ, Yu HZ, Mo CJ, et al. Clinical study of the prediction of malignancy in thyroid nodules: Modified score versus 2017 American College of Radiology's Thyroid Imaging Reporting and Data System Ultrasound Lexicon[J]. Ultrasound Med Biol,2019, 45(7):1627-1637.
[23] Huang ST, Zhang B, Yin HL, et al. Incremental diagnostic value of shear wave elastography combined with contrast-enhanced ultrasound in TI-RADS category 4a and 4b nodules[J]. J Med Ultrason (2001), 2020, 47(3):453-462.
[24] 郭倩倩, 牛丽娟. 超声造影诊断甲状腺癌颈部转移性淋巴结的研究进展[J]. 癌症进展, 2019, 17(7):758-759,783.
[25] Hong YR, Luo ZY, Mo GQ, et al. Role of contrast-enhanced ultrasound in the pre-operative diagnosis of cervical lymph node metastasis in patients with papillary thyroid carcinoma[J]. Ultrasound Med Biol, 2017, 43(11):2567-2575.
[26] Zhan J, Diao XH, Chen Y, et al. Homogeneity parameter in contrast-enhanced ultrasound imaging improves the classification of abnormal cervical lymph node after thyroidectomy in patients with papillary thyroid carcinoma[J]. Biomed Res Int, 2019, 2019:9296010.
[27] Chen L, Chen L, Liu J, et al. Value of qualitative and quantitative contrast-enhanced ultrasound analysis in preoperative diagnosis of cervical lymph node metastasis from papillary thyroid carcinoma[J]. J Ultrasound Med, 2020, 39(1):73-81.
[28] Kim HJ, Choi IH, Jin SY, et al. Efficacy of shear-wave elastography for detecting postoperative cervical lymph node metastasis in papillary thyroid carcinoma[J]. Int J Endocrinol, 2018, 2018:9382649.
[29] Jung WS, Kim JA, Son EJ, et al. Shear wave elastography in evaluation of cervical lymph node metastasis of papillary thyroid carcinoma: elasticity index as a prognostic implication[J]. Ann Surg Oncol, 2015, 22(1):111-116.
[30] You J, Chen J, Xiang F, et al. The value of quantitative shear wave elastography in differentiating the cervical lymph nodes in patients with thyroid nodules[J]. J Med Ultrason (2001), 2018, 45(2):251-259.
[31] Suh CH, Choi YJ, Baek JH, et al. The diagnostic performance of shear wave elastography for malignant cervical lymph nodes: A systematic review and meta-analysis[J]. Eur Radiol, 2017, 27(1):222-230.
[32] Zhan J, Diao X, Chen Y, et al. Predicting cervical lymph node metastasis in patients with papillary thyroid cancer (PTC) -Why contrast-enhanced ultrasound(CEUS) was performed before thyroidectomy[J]. Clin Hemorheol Microcirc, 2019, 72(1):61-73.
[33] Tao L, Zhou W, Zhan W, et al. Preoperative prediction of cervical lymph node metastasis in papillary thyroid carcinoma via conventional and contrast-enhanced ultrasound[J/OL]. J Ultrasound Med, 2020-04-30[2020-08-19]. https://pubmed.ncbi.nlm.nih.gov/32352187/.
[34] 周萍, 周伟, 周建桥, 等. 甲状腺乳头状癌的灰阶超声造影特征与颈部淋巴结转移的关系[J]. 诊断学理论与实践, 2011, 10(1):45-49.
[35] Wang D, Zheng X, Li M. Correlation analysis between the pre-operative contrast-enhanced ultrasound parameters and biological characteristics of papillary thyroid carcinoma and associated risk factors for prognosis after radiofrequency ablation[J]. Exp Ther Med, 2020, 20(2):1575-1581.
[36] Liu Y, Liu H, Qian CL, et al. Utility of quantitative contrast-enhanced ultrasound for the prediction of extracapsular extension in papillary thyroid carcinoma[J]. Sci Rep, 2017, 7(1):1472.
[37] Xu JM, Xu XH, Xu HX, et al. Prediction of cervical lymph node metastasis in patients with papillary thyroid cancer using combined conventional ultrasound, strain elastography, and acoustic radiation force impulse (ARFI) elastography[J]. Eur Radiol, 2016, 26(8):2611-2622.
[38] Xu JM, Chen YJ, Dang YY, et al. Association between preoperative US, elastography features and prognostic factors of papillary thyroid cancer with BRAF V600E mutation[J]. Front Endocrinol (Lausanne), 2020, 10:902.
[39] Dong Y, Mao M, Zhan W, et al. Size and ultrasound features affecting results of ultrasound-guided fine-needle aspiration of thyroid nodules[J]. J Ultrasound Med, 2018, 37(6):1367-1377.
[40] 韩煜东, 夏丛燕, 卢晓莉, 等. 22G和25G细针对超声引导下甲状腺富血供结节穿刺标本满意率的比较[J]. 临床与病理杂志, 2019, 39(2):349-352.
[41] 詹维伟, 倪晓枫. 细针穿刺抽吸活检在甲状腺结节诊断中的应用[J]. 诊断学理论与实践, 2014, 13(5):472-475.
[42] Li F, Luo H. Comparative study of thyroid puncture biopsy guided by contrast-enhanced ultrasonography and conventional ultrasound[J]. Exp Ther Med, 2013, 5(5):1381-1384.
[43] Yildirim D, Gurses B, Gurpinar B, et al. The value of ultrasound elastography-guided fine-needle aspiration biopsy of thyroid nodules in reducing nondiagnostic results[J]. J Med Ultrason (2001), 2013, 40(2):169-174.
[44] Landau E, del Re D, Kviatkovsky B, et al. Elastography-targeted thyroid nodule aspiration: A novel approach[J]. J Clin Imaging Sci, 2017, 7:4.
[45] Zhang L, Zhou W, Zhan W, et al. Percutaneous laser ablation of unifocal papillary thyroid microcarcinoma: utility of conventional ultrasound and contrast-enhanced ultrasound in assessing local therapeutic response[J]. World J Surg, 2018, 42(8):2476-2484.
[46] Zhang L, Zhou W, Zhan W. Role of ultrasound in the assessment of percutaneous laser ablation of cervical metastatic lymph nodes from thyroid carcinoma[J]. Acta Radiol, 2018, 59(4):434-440.
[47] Schiaffino S, Serpi F, Rossi D, et al. Reproducibility of ablated volume measurement is higher with contrast-enhanced ultrasound than with B-mode ultrasound after benign thyroid nodule radiofrequency ablation-A preliminary study[J]. J Clin Med, 2020, 9(5):1504.
[48] Yan L, Luo Y, Zhang M, et al. Vital volume increase versus clinical evaluation as the indication of additional radiofrequency ablation for benign thyroid nodule: A single center retrospective study[J]. Int J Hyperthermia, 2020, 37(1):777-785.
[49] Jiao Z, Luo Y, Song Q, et al. Roles of contrast-enhanced ultrasonography in identifying volume change of benign thyroid nodule and optical time of secondary radiofrequency ablation[J]. BMC Med Imaging, 2020, 20(1):79.
[50] Andrioli M, Valcavi R. The peculiar ultrasonographic and elastographic features of thyroid nodules after treatment with laser or radiofrequency: Similarities and differences[J]. Endocrine, 2014, 47(3):967-968.
[51] Idiz UO, Aysan E, Elmas L, et al. The place of elastography in evaluating the efficacy of radiofrequency ablation of thyroid nodules[J]. Am Surg, 2017, 83(11):1228-1234.
文章导航

/